Abciximab combined with angioplasty in a patient with renal artery stent subacute thrombosis

Catheterization and Cardiovascular Diagnosis

Volumn 45, Issue 3, 1998, Pages 272-274

  Berkompas, Duane C ^a  

^a Thoracic Cardiovascular Institute   (United States)

Author keywords

Abciximab; Angioplasty; Platelet glycoprotein IIb IIIa inhibitor; Renal artery; Stenting

Indexed keywords

ABCIXIMAB; HEPARIN; LABETALOL; NIFEDIPINE; OFLOXACIN; TERAZOSIN; TOBRAMYCIN; VANCOMYCIN;

ADULT; ANGIOPLASTY; ARTICLE; CASE REPORT; FEMALE; HUMAN; HYPERTENSION; KIDNEY ANGIOGRAPHY; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; NEPHRITIS; POSTOPERATIVE COMPLICATION; RENAL ARTERY THROMBOSIS; STENT; TREATMENT OUTCOME;

ANGIOPLASTY; ANTIBODIES, MONOCLONAL; ANTICOAGULANTS; BLOOD FLOW VELOCITY; FEMALE; FOLLOW-UP STUDIES; GRAFT OCCLUSION, VASCULAR; HEPARIN; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; INFUSIONS, INTRAVENOUS; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROSTHESIS FAILURE; RENAL ARTERY; RENAL ARTERY OBSTRUCTION; REOPERATION; STENTS;

EID: 0031727669     PISSN: 00986569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0304(199811)45:3<272::AID-CCD12>3.0.CO;2-W     Document Type: Article

References (15)

1. Coller BS: Blockade of platelet GP IIb/IIIa receptors as an antithrombotic strategy. Circulation 92:2373-2380, 1995.
2. Lefkovits J, Ivanhoe RJ, Califf RM, Bergelson BA, Anderson KM, Stoner GL, Weisman HF, Topol EJ, for the EPIC Investigators: Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol 77:1045-1051, 1996.
3. Topol EJ, Califf RM, Weisman HF, Ellis SG, Tcheng JE, Worley S, Ivanhoe R, George BS, Fintel D, Weston M, Sigmon K, Anderson KM, Lee KL, Willerson KT, on behalf of The EPIC investigators: Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: Results at six months. Lancet 343:881-886, 1994.
4. 3 blockade with percutaneous coronary intervention. JAMA 278:479-484, 1997.
5. The EPIC Investigators: Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 220:956-961, 1994.
6. Gold HK, Garabedian HD, Dinsmore RE, Guerrero LJ, Cigarroa JE, Palacios IF, Leinbach RC: Restoration of coronary flow in myocardial infarction by intravenous chimeric 7E3 antibody without exogenous plasminogen activators: Observations in animals and humans. Circulation 95:1755-1759, 1997.
7. Challapalli RM, Eisenberg MJ, Sigmon K, Lemberger J: Platelet glycoprotein IIb/IIIa monoclonal antibody (c7E3) reduces distal embolization during percutaneous intervention of saphenous vein grafts. Circulation 92(suppl I):I-607, 1997. Abstract 2908.
8. The EPILOG Investigators: Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 336:1689-1696, 1997.
9. Guzman LA, Whitlow PL, Topol EJ, Ellis SG: A platelet glycoprotein IIb/IIIa inhibitor (ReoPro®) as an adjunctive therapy in elective stenting: Initial experience with safety and efficacy. J Invasive Cardiol 8:46 (Abstract TCT-61), 1996.
10. Tepe G, Duda SH, Erley CM, Schott U, Huppert PE: The adjuvant use of the monoclonal antibody c7E3 in peripheral arterial thrombolysis. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 166:254-257, 1997.
11. Lincoff AM, Tcheng JE, Califf RM, Bass T, Popma JJ, Tierstein PS, Kleiman NS, Hattel LJ, Anderson HV, Ferguson JJ, Cabot CF, Anderson KM, Berdan LG, Musco MH, Weisman HF, Topol EJ: Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3 Fab) during percutaneous coronary revascularization. Am J Cardiol 79:286-291, 1997.
12. The CAPTURE Investigators: Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: The CAPTURE study. Lancet 349:1429-1435, 1997.
13. Wallace RC, Furlan AJ, Moliterno DJ, Stevens GHJ, Masaryk TJ, Perl JII: Basilar artery rethrombosis: Successful treatment with platelet glycoprotein IIb/IIIa receptor inhibitor. AJNR 18:1257-1260, 1997.
14. Vogt A, Scheinert S, Dörr G, Biameno G: Use of ReoPro® (abciximab) after excimer laser assisted angioplasty in peripheral arterial occlusive disease. Am J Cardiol 80:5S, 1997.
15. Haas PC, Yaryura R, Krajcer Z, Strickman NE: Use of a glycoprotein IIb/IIIa receptor antagonist (abciximab) in peripheral vascular interventions. Am J Cardiol 80: 46S, 1997.